ALI revenues decline in Q3Purchasing delays related to the year 2000 problem weighed down financial results at ultrasound miniPACS firm ALI Technologies. During its fiscal third quarter (end-June), ALI posted revenues of $3.7 million (U.S.), an
Purchasing delays related to the year 2000 problem weighed down financial results at ultrasound miniPACS firm ALI Technologies. During its fiscal third quarter (end-June), ALI posted revenues of $3.7 million (U.S.), an increase of 7% over the same period in 1998, but a decrease of 22% from second-quarter 1999 (end-March). The company attributed the decrease to Y2K software conformance issues its clients are facing.
During the quarter, the company incurred a net loss of $178,302, and sustained a charge of $231,058 for restruct-uring costs related to its purchase of Olicon Imaging Systems (PNN 7/99). ALI reported that its integration of Olicons image management business is almost complete.
ALI also announced that two multimodality sites are in clinical operation under its introductory beta site pilot program (PNN 12/98), which will be completed in the fall. In addition, the Vancouver, BC-based company has purchase commitments for three additional multimodality systems from Pitt County Memorial Hospital in Greenville, NC, the University of California, Los Angeles Santa Monica Clinic in Santa Monica, CA, and the Texas Health System-Arlington Memorial South Medical Center in Dallas.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.